| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/25/2009 | EP2026838A2 A METHOD FOR DELIVERING A HUMAN CHORIONIC GONADOTROPIN (hCG) VACCINE FOR LONG-ACTING ANTIBODY PRODUCTION |
| 02/25/2009 | EP2026835A1 Nasal and buccal compositions for controlling snoring |
| 02/25/2009 | EP2026832A2 Cladribine regimen for treating multiple sclerosis |
| 02/25/2009 | EP2026823A2 Site-specific intestinal delivery of adsorbents, alone or in combination with degrading molecules |
| 02/25/2009 | EP2026822A1 Topical treatment for diseases of eye surface |
| 02/25/2009 | EP2026816A2 Treprostinil administration using a metered dose inhaler |
| 02/25/2009 | EP2026815A1 Controlled released preparations of oxcarbazepine having sigmoidal release profile |
| 02/25/2009 | EP2026787A1 Tablet formulation comprising repaglinide and metformin |
| 02/25/2009 | EP2026785A1 Propellant-free inhalation aerosol formulation containing ipratropium bromide and salbutamol sulfate |
| 02/25/2009 | EP2026784A1 Aerosol formulation containing ipratropium bromide and salbutamol sulfate |
| 02/25/2009 | EP2026772A1 Nanoparticles of chitosan and hyaluronan for the administration of active molecules |
| 02/25/2009 | EP2026771A2 Microspheres comprising nanocapsules containing a lipophilic drug |
| 02/25/2009 | EP2026770A1 Pharmaceutical formulations and compositions of a selective antagonist of either cxcr2 or both cxcr1 and cxcr2 and methods of using the same for treating inflammatory disorders |
| 02/25/2009 | EP2026769A1 Bilayer tablet for preventing cardiovascular events |
| 02/25/2009 | EP2026768A2 Multiple unit pharmaceutical formulation |
| 02/25/2009 | EP2026767A1 Production of enveloped pharmaceutical dosage forms |
| 02/25/2009 | EP2026766A1 Tablet composition with a prolonged release of tamsulosin |
| 02/25/2009 | EP2026764A1 A sustained-release intraocular implant comprising a vasoactive agent |
| 02/25/2009 | EP2026763A1 A method to reduce the symptoms of heartburn and gastro-oesophageal reflux disease (gerd) by specific polysaccharides |
| 02/25/2009 | EP2026762A1 Inhalant aerosol formulations containing ethanol |
| 02/25/2009 | EP2026761A1 Inhalant propellant-free aerosol formulation |
| 02/25/2009 | EP2026760A2 Transdermal therapeutic system |
| 02/25/2009 | EP2026743A1 Paste for use as a bandage on mucous membranes of the oral cavity or on the skin |
| 02/25/2009 | EP1915128B1 Sterile, drop-forming, multi-phase, emulsifier-free ophthalmic product |
| 02/25/2009 | EP1758555B1 Triterpene-containing oleogel-forming agent, triterpene-containing oleogel and method for producing a triterpene-containing oleogel |
| 02/25/2009 | EP1755617A4 Perfluorocarbon-soluble compounds |
| 02/25/2009 | EP1700595B1 Tablets having an emulsified polymer matrix for the controlled emission of gas, and production process |
| 02/25/2009 | EP1651196B1 An abuse-resistant transdermal dosage form comprising an active agent and an antagonist to said active agent |
| 02/25/2009 | EP1638532B1 Flupirtin injectable galenic form |
| 02/25/2009 | EP1581285B1 Drug solution density adjustment systems and methods |
| 02/25/2009 | EP1530469B1 Transdermal dosage form comprising an active agent and a salt and free-base form of an antagonist |
| 02/25/2009 | EP1474117B1 Composition for inhalation |
| 02/25/2009 | EP1448709B1 Method for preparing gels |
| 02/25/2009 | EP1392270B1 Abuse resistant pharmaceutical composition containing capsaicin |
| 02/25/2009 | EP1365651A4 Composition and methods for modulation of vascular structure and/or function |
| 02/25/2009 | EP1247532B1 Composition promoting lacrimal secretion |
| 02/25/2009 | EP1169050B1 Ocular treatment using cyclosporin-a derivatives |
| 02/25/2009 | EP0966267B1 N-acyl phosphatidylethanolamine-mediated liposomal drug delivery |
| 02/25/2009 | CN201197815Y Loratadine and pseudoephedrine sulfate sustained and controlled release capsules |
| 02/25/2009 | CN101374554A Gelling hydrophobic injectable polymer compositions |
| 02/25/2009 | CN101374552A Medicine for transnasal administration |
| 02/25/2009 | CN101374541A Use of a topical composition containing epidermal growth factor (EGF) for diabetic foot amputation prevention |
| 02/25/2009 | CN101374530A Chitosan and heparin nanoparticles |
| 02/25/2009 | CN101374521A Tamper resistant dosage forms |
| 02/25/2009 | CN101374506A Method for producing a particle comprising a gas core and a shell and particles thus obtained |
| 02/25/2009 | CN101374505A Multiple unit type sustained release oral formulation and process for the preparation thereof |
| 02/25/2009 | CN101374504A Zaltoprofen-containing sustained release tablet and process for the preparation thereof |
| 02/25/2009 | CN101374503A Quickly disintegrating tablet produced by direct dry-tabletting |
| 02/25/2009 | CN101374502A Medicament for topical use |
| 02/25/2009 | CN101374501A Composition and method of use thereof |
| 02/25/2009 | CN101374500A Film-shaped drug forms for use in the oral cavity (wafers) |
| 02/25/2009 | CN101374499A Topical mecamylamine formulations for ocular administration and uses thereof |
| 02/25/2009 | CN101374498A Botulinum nanoemulsions |
| 02/25/2009 | CN101374497A Penetrating formulation |
| 02/25/2009 | CN101372499A Novel medicament having antiinflammatory activity |
| 02/25/2009 | CN101371925A Nano silver-cell growth factor sustained-release composite body as well as preparation method and use thereof |
| 02/25/2009 | CN101371922A Water-bearing liquid transformation reaction vaccine formulation for oral mucous membrane administration |
| 02/25/2009 | CN101371916A Gongyankang dropping pill formulation and preparation method thereof |
| 02/25/2009 | CN101371915A Method for preparing minor decoction of Bupleurum formulation |
| 02/25/2009 | CN101371909A Medicine for treating carcinoma of stomach and preparation method thereof |
| 02/25/2009 | CN101371908A Gelatin-coated pill for preventing and treating calculi in vivo |
| 02/25/2009 | CN101371905A Chinese medicine lozenge for treating throat disease |
| 02/25/2009 | CN101371899A Medicine for treating tympanitis |
| 02/25/2009 | CN101371891A Composition of ginseng, astragalus and Ganoderma lucidum and production method |
| 02/25/2009 | CN101371890A Medicaments composite for treating gland hyperplasia and breast cancer and preparation method thereof |
| 02/25/2009 | CN101371888A Red date powder for good sleep |
| 02/25/2009 | CN101371882A Method for preparing Artemisia capillaris decoction formulation |
| 02/25/2009 | CN101371881A Chinese medicine soft capsule formulation for treating hepatosis and preparation technique thereof |
| 02/25/2009 | CN101371879A Aconitum sinomontanum transdermal paster and preparation method thereof |
| 02/25/2009 | CN101371877A Qi tian dropping pill extract and Qi tian dropping pill as well as method for producing the same |
| 02/25/2009 | CN101371872A Method for producing hard capsule using Acanthopanax senticosus and schisandra chinensis |
| 02/25/2009 | CN101371870A Method for preparing sweet clover extract and medicinal value thereof |
| 02/25/2009 | CN101371869A Inhibitor originated from alpha-glucosidase of natto and preparation method thereof |
| 02/25/2009 | CN101371864A Medicament for treating varix and preparation method thereof |
| 02/25/2009 | CN101371858A Patrinia scaniosaefolia extract as well as preparation method and application thereof |
| 02/25/2009 | CN101371857A Composite medicament for inhibiting tumor and preparation method thereof as well as technique field |
| 02/25/2009 | CN101371847A Use of pseudo ginsengenin in preparing medicament for resisting platelet aggregation |
| 02/25/2009 | CN101371845A Medicament composition for curing mouth ulcer |
| 02/25/2009 | CN101371844A Sticking tablet for curing mouth ulcer using mometasone furoate as active component |
| 02/25/2009 | CN101371843A Use of loxapine and amoxapine for the perparation of a medicament for the treatment of pain |
| 02/25/2009 | CN101371842A Lornoxicam microsphere and preparation method thereof |
| 02/25/2009 | CN101371841A Crystallization type Entecavir formulation as well as preparation method and use thereof |
| 02/25/2009 | CN101371836A Paroxetine enteric sustained-release composition |
| 02/25/2009 | CN101371835A Medicament composition containing l-rebeprazole and uses thereof |
| 02/25/2009 | CN101371828A Hypocrellin liposome preparation and preparation method thereof |
| 02/25/2009 | CN101371826A Percutaneous absorption patch |
| 02/25/2009 | CN101371825A Oral sticking tablets using fluticasone propionate as active component |
| 02/25/2009 | CN101371824A Oral cavity pasting tablets using Methylprednisolone and derivatives thereof as active components |
| 02/25/2009 | CN101371823A Technique for preparing double-acetyl emodic acid sustained-release capsules |
| 02/25/2009 | CN101371822A Stomach detention sustained and controlled release medicament releasing system and preparation method |
| 02/25/2009 | CN101371821A Anti-cancer medicine composition containing metabolism-resistance medicament |
| 02/25/2009 | CN101371820A Anticancer sustained-release agent containing methotrexate potentiating agent |
| 02/25/2009 | CN100464188C Quality control method of medicinal preparation for treating lypemania |
| 02/25/2009 | CN100464186C Quality control method of compound Chinese medicine preparation |
| 02/25/2009 | CN100463906C Extraction method for daphnoretin |
| 02/25/2009 | CN100463697C Hydrogenated castor oil dispersed in a lipid for pharmaceutically elegant external ointments |
| 02/25/2009 | CN100463693C Interferon oculentum |
| 02/25/2009 | CN100463691C Method for preparing gel of relieving a cough |
| 02/25/2009 | CN100463690C Chinese medicine tea bag |
| 02/25/2009 | CN100463689C Method for preparing gel for wean to remove heat |